Assuming just 10% of eligible beneficiaries use Wegovy in a given year, and assuming a 50% rebate on the list price, Medicare would incur nearly $3 billion in additional net Part D spending for one year for this one drug alone.KFF also finds that beneficiaries who take Wegovy could face monthly out-of-pocket costs of $325 to $430 if they have to pay a percentage of the drugs $1,300 list price for a months supply
GLP-1 receptor agonists are currently prescribed for people with type 2 diabetes, those with obesity (defined as individuals with a BMI of 30 or higher, or a BMI of 27 with obesity-related health conditions such as hypertension or high cholesterol),
You may need a lower dose of insulin or other treatments during this time compared to in pregnancy, or before you became pregnant
Specifically, thyroid function should be rechecked 6-8 weeks after starting or titrating GLP-1 therapy, after significant weight loss, or after any levothyroxine dose change
What side effects should I watch for when combining semaglutide and antidepressants
These injections are changing how we think about weight loss and bringing hope to people who need it